Kyverna Therapeutics Announces Appointment of New Chief Financial Officer
June 30, 2025
Dr. Marc Grasso brings more than 25 years of public company, capital markets and investment banking expertise to the role Kyverna Therapeutics, a clinical-stage biopharmaceutical company focused